Barclays on U.S. Paper & Packaging: FX; A Symptom Not A Diagnosis

June 7, 2012 2:50 PM EDT Send to a Friend
Get Alerts IP Hot Sheet
Price: $46.50 -2.62%

Rating Summary:
    12 Buy, 1 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 13 | Down: 28 | New: 14
Trade IP Now!
Barclays on U.S. Paper & Packaging: FX; A symptom not a diagnosis

Analyst, Scott L. Gaffner updated recent investor inquiries by saying, "The rising dollar versus Euro and Real could reduce 2012 Paper & Packaging EPS on average 3%, but this doesn't fully explain the nearly 10% drop in stock prices. We believe FX is principally a symptom of weaker economic growth, and not a diagnosis of the impact on stock prices. Furthermore, companies in our space with higher levels of exposure to Europe have seen their stock price decline 15%-20% despite an implied FX impact to EPS of around 5%."

Gaffner said investors should be concerned, but only as a 'Secondary Impact' to earnings. U.S. Paper and Packaging stocks are already down approx. 12%, although companies with high exposure to Europe are down even more. On the positive side, easy comparisons from last year, plus World Cup Soccer and the Olympics, should help reduce fears and create opportunity.

Stocks of Note: Int'l Paper (NYSE: IP), Orient Paper, Inc. (NYSE: ONP), Clearwater (NYSE: CLW) and PH Glatfelter (NYSE: GLT)


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

Analyst Comments, Retail Sales

Related Entities

Barclays, Earnings

Add Your Comment